Please login to the form below

Not currently logged in
Email:
Password:

Sirturo

This page shows the latest Sirturo news and features for those working in and with pharma, biotech and healthcare.

AZ, BMS and Boehringer among UK Prix Galien finalists

AZ, BMS and Boehringer among UK Prix Galien finalists

Janssen's Sirturo, the first tuberculosis medication to be approved in four decades.

Latest news

  • UK Prix Galien opens for entries UK Prix Galien opens for entries

    The 2014 UK Prix Galien was won by Bexsero, the first ever vaccine to treat invasive meningococcal disease, and Sirturo, the first TB medication to be approved in four decades.

  • Study shows Otsuka's TB drug works even in worst cases Study shows Otsuka's TB drug works even in worst cases

    Deltyba was approved for marketing last year in Europe, joining Johnson &Johnson's Sirturo (bedaquiline) as the first new therapies for multidrug-resistant TB in decades.

  • Novartis' Bexsero triumphs at UK Prix Galien Novartis' Bexsero triumphs at UK Prix Galien

    Novartis' Bexsero triumphs at UK Prix Galien. The Awards also saw Janssen's Sirturo pick up the Orphan Drug prize. ... Orphan Drug award for Janssen's Sirturo. Pictured (l-r): Dr Ramesh Dass - Janssen's European commercial lead for Sirturo, Sir Kevin

  • Otsuka wins approval for TB drug Deltyba Otsuka wins approval for TB drug Deltyba

    This week the European Commission granted the Japanese firm authorisation to market Deltyba (delamanid) almost two months after backing Johnson &Johnson's Sirturo (bedaquiline) in a similar indication.

  • J&J gets EU green light for novel TB drug J&J gets EU green light for novel TB drug

    J&J gets EU green light for novel TB drug. Sirturo approved to treat multidrug resistant form of the disease. ... Johnson &Johnson has secured approval in Europe for Sirturo, one of the first new classes of tuberculosis (TB) therapy to reach the EU

More from news
Approximately 4 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • The world is our laboratory The world is our laboratory

    We developed Sirturo (bedaquiline), the first new medicine for tuberculosis in 40 years, which received the UK Prix Galien Award for most innovative orphan drug in October 2014.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics